{"id":51228,"date":"2026-06-23T08:26:37","date_gmt":"2026-06-23T06:26:37","guid":{"rendered":"https:\/\/semaxpolska.com\/?p=51228"},"modified":"2026-06-22T09:23:57","modified_gmt":"2026-06-22T07:23:57","slug":"selank-vs-afobazole-dva-ruske-leky-proti-uzkosti-s-odlisnym-mechanismem-ucinku","status":"publish","type":"post","link":"https:\/\/bioevidencehub.com\/cs\/selank-vs-afobazole-dwa-rosyjskie-srodki-przeciwlekowe-o-odmiennym-dzialaniu\/","title":{"rendered":"Selank vs Afobazol \u2013 Dwa rosyjskie \u015brodki przeciwl\u00e4\u00e4kov\u00e9 s odli\u0161n\u00fdm \u00fa\u010dinkem"},"content":{"rendered":"

Selank a Afobazol jsou dva rusk\u00e9 p\u0159\u00edpravky vyvinut\u00e9 pro sn\u00ed\u017een\u00ed \u00fazkosti a zlep\u0161en\u00ed odolnosti v\u016f\u010di stresu. P\u0159esto\u017ee oba vykazuj\u00ed anxiolytick\u00e9 \u00fa\u010dinky bez v\u00fdrazn\u00e9ho zp\u016fsoben\u00ed ospalosti, li\u0161\u00ed se ve sv\u00e9 struktu\u0159e, zp\u016fsobu pod\u00e1n\u00ed, mechanismu \u00fa\u010dinku a rychlosti n\u00e1stupu \u00fa\u010dink\u016f.<\/p>\n

Co to s\u0105 Selank i Afobazole?<\/h3>\n

Selank je syntetick\u00fd heptapeptid slo\u017een\u00fd ze sedmi aminokyselin. Byl navr\u017een jako analog p\u0159irozen\u00e9ho peptidu tuftsinu, kter\u00fd se pod\u00edl\u00ed na komunikaci mezi imunitn\u00edm a nervov\u00fdm syst\u00e9mem. Selank se pod\u00e1v\u00e1 nosn\u011b a studie nazna\u010duj\u00ed, \u017ee m\u016f\u017ee velmi rychle proniknout do centr\u00e1ln\u00edho nervov\u00e9ho syst\u00e9mu. Byl vyvinut v Rusku a na Ukrajin\u011b v 90. letech a je tam schv\u00e1len k pou\u017eit\u00ed p\u0159i l\u00e9\u010db\u011b \u00fazkostn\u00fdch poruch a stav\u016f souvisej\u00edc\u00edch se stresem.<\/p>\n

Afobazol (fabomotizol) je naopak syntetick\u00e1 chemick\u00e1 slou\u010denina dostupn\u00e1 ve form\u011b tablet. Byl rovn\u011b\u017e vyvinut v Rusku koncem 90. let. P\u016fsob\u00ed p\u0159edev\u0161\u00edm aktivac\u00ed sigma-1 receptor\u016f, kter\u00e9 se pod\u00edlej\u00ed na regulaci bun\u011b\u010dn\u00e9 odezvy na stres. Stejn\u011b jako Selank byl navr\u017een tak, aby nezp\u016fsoboval v\u00fdznamnou sedaci.<\/p>\n

Jak se dost\u00e1vaj\u00ed do organismu?<\/h2>\n
\n
\n
\n\n\n\n\n\n\n\n\n
\u010cech<\/th>\nSelank<\/th>\nAfobazol<\/th>\n<\/tr>\n<\/thead>\n
Zp\u016fsob pod\u00e1n\u00ed<\/strong><\/td>\nNosn\u00ed sprej \u2013 n\u011bkolik st\u0159ik\u016f do ka\u017ed\u00e9 nosn\u00ed d\u00edrky<\/td>\nTableta pod\u00e1van\u00e1 or\u00e1ln\u011b, obvykle 3kr\u00e1t denn\u011b<\/td>\n<\/tr>\n
Jak rychle se dostane do mozku<\/strong><\/td>\nVelmi rychle \u2013 skrze nosn\u00ed dutinu p\u0159\u00edmo do mozku, s vynech\u00e1n\u00edm tr\u00e1vic\u00edho procesu<\/td>\nVst\u0159eb\u00e1v\u00e1 se tr\u00e1vic\u00edm traktem; maxim\u00e1ln\u00ed koncentrace v krvi je dosa\u017eena p\u0159ibli\u017en\u011b po 1 hodin\u011b<\/td>\n<\/tr>\n
Jak dlouho to trv\u00e1<\/strong><\/td>\nHlavn\u00ed peptid se rozkl\u00e1d\u00e1 p\u0159ibli\u017en\u011b za 2 minuty, ale aktivn\u00ed fragmenty mohou p\u016fsobit 3\u20134 hodiny<\/td>\nHlavn\u00ed slou\u010denina je eliminov\u00e1na relativn\u011b rychle (p\u0159ibli\u017en\u011b 50 minut), zat\u00edmco jej\u00ed metabolit z\u016fst\u00e1v\u00e1 aktivn\u00ed a\u017e 6 hodin.<\/td>\n<\/tr>\n
Jak je odstra\u0148ov\u00e1n z t\u011bla<\/strong><\/td>\nRozkl\u00e1d\u00e1 se na ne\u0161kodn\u00e9 b\u00edlkovinn\u00e9 fragmenty a vylu\u010duje se ledvinami b\u011bhem 24 hodin<\/td>\nP\u0159ibli\u017en\u011b 85% se vylu\u010duje ledvinami a 15% tr\u00e1vic\u00edm traktem; zcela se vylou\u010d\u00ed b\u011bhem jednoho dne<\/td>\n<\/tr>\n
Kolik l\u00e1tek se st\u00e1v\u00e1 biologicky dostupn\u00fdmi<\/strong><\/td>\nVysok\u00e1 dostupnost v mozku d\u00edky naz\u00e1ln\u00ed aplikaci a obch\u00e1zen\u00ed jatern\u00edho metabolismu<\/td>\nP\u0159ibli\u017en\u011b 43\u2013551 TP30T z podan\u00e9 d\u00e1vky se dost\u00e1v\u00e1 do krevn\u00edho ob\u011bhu po pr\u016fchodu j\u00e1try<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n<\/div>\n
\n

Jak sni\u017euj\u00ed \u00fazkost?<\/h2>\n

Oba prepar\u00e1ty redukuj\u00ed p\u0159\u00edznaky \u00fazkosti, ani\u017e by p\u016fsobily jako typick\u00e9 sedativum nebo hypnotikum. \u017d\u00e1dn\u00fd z nich nebyl navr\u017een tak, aby zp\u016fsoboval ospalost.<\/p>\n

\n
\n
\n\n\n\n\n\n\n\n\n\n
\u010cech<\/th>\nSelank<\/th>\nAfobazol<\/th>\n<\/tr>\n<\/thead>\n
Hlavn\u00ed anxiolytick\u00fd \u00fa\u010dinek<\/strong><\/td>\nPodporuje \u010dinnost GABA \u2013 hlavn\u00edho inhibi\u010dn\u00edho neurotransmiteru \u2013 bez nadm\u011brn\u00e9ho potla\u010dov\u00e1n\u00ed mozkov\u00e9 aktivity<\/td>\nAktivuje receptory sigma-1, kter\u00e9 pom\u00e1haj\u00ed bu\u0148k\u00e1m zvl\u00e1dat stresov\u00e9 sign\u00e1ly; ovliv\u0148uje tak\u00e9 melatoninov\u00e9 receptory<\/td>\n<\/tr>\n
Vliv na zdrav\u00ed mozku<\/strong><\/td>\nZvy\u0161uje hladinu BDNF a NGF, podporuje komunikaci mezi neurony, pam\u011b\u0165 a soust\u0159ed\u011bn\u00ed<\/td>\nM\u016f\u017ee zvy\u0161ovat BDNF prost\u0159ednictv\u00edm aktivace sigma-1 receptor\u016f, \u010d\u00edm\u017e podporuje regeneraci nervov\u00fdch bun\u011bk.<\/td>\n<\/tr>\n
Vliv na n\u00e1ladu<\/strong><\/td>\nJemn\u011b p\u016fsob\u00ed na serotoninov\u00e9 a dopaminov\u00e9 dr\u00e1hy a vykazuje m\u00edrn\u00fd \u00fa\u010dinek zlep\u0161uj\u00edc\u00ed n\u00e1ladu<\/td>\nV\u00fdhody se t\u00fdkaj\u00ed p\u0159edev\u0161\u00edm regulace stresu a \u00fazkosti, nikoli p\u0159\u00edm\u00e9ho zlep\u0161en\u00ed n\u00e1lady<\/td>\n<\/tr>\n
Vliv na imunitn\u00ed syst\u00e9m<\/strong><\/td>\nVykazuje imunomodula\u010dn\u00ed vlastnosti a m\u016f\u017ee ovliv\u0148ovat regulaci z\u00e1n\u011btliv\u00fdch proces\u016f<\/td>\nProtiz\u00e1n\u011btliv\u00fd \u00fa\u010dinek se zd\u00e1 b\u00fdt v\u00fdrazn\u011b slab\u0161\u00ed<\/td>\n<\/tr>\n
Riziko sedace<\/strong><\/td>\nNebyla pozorov\u00e1na v\u00fdznamn\u00e1 ospalost<\/td>\nNebyla pozorov\u00e1na v\u00fdznamn\u00e1 ospalost<\/td>\n<\/tr>\n
Riziko z\u00e1vislosti<\/strong><\/td>\nNedostatek d\u016fkaz\u016f o toleranci, z\u00e1vislosti nebo abstinen\u010dn\u00edch p\u0159\u00edznac\u00edch<\/td>\nV studi\u00edch trvaj\u00edc\u00edch a\u017e 12 t\u00fddn\u016f nebyly hl\u00e1\u0161eny \u017e\u00e1dn\u00e9 z\u00e1vislosti ani abstinen\u010dn\u00ed p\u0159\u00edznaky<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n<\/div>\n
\n

Jak efektivn\u011b funguj\u00ed?<\/h2>\n
\n
\n
\n\n\n\n\n\n\n\n\n\n\n\n
\u010cech<\/th>\nSelank<\/th>\nAfobazol<\/th>\n<\/tr>\n<\/thead>\n
Za\u010d\u00e1tek provozu<\/strong><\/td>\nRychl\u00e9 \u2013 prvn\u00ed \u00fa\u010dinky se mohou objevit b\u011bhem 20\u201360 minut<\/td>\nPostupn\u00e9 \u2013 pln\u00fd anxiolytick\u00fd \u00fa\u010dinek se obvykle rozv\u00edj\u00ed po 2\u20134 t\u00fddnech pravideln\u00e9ho u\u017e\u00edv\u00e1n\u00ed<\/td>\n<\/tr>\n
Typov\u00e9 d\u00e1vkov\u00e1n\u00ed pou\u017e\u00edvan\u00e9 ve studi\u00edch<\/strong><\/td>\n400\u2013600 mikrogram\u016f do nosu, 1\u20133kr\u00e1t denn\u011b<\/td>\n10 mg t\u0159ikr\u00e1t denn\u011b (celkem 30 mg denn\u011b)<\/td>\n<\/tr>\n
Hlavn\u00ed oblasti v\u00fdzkumu<\/strong><\/td>\nGeneralizovan\u00e1 \u00fazkost, kr\u00e1tkodob\u00fd stres, probl\u00e9my s pam\u011bt\u00ed a koncentrac\u00ed souvisej\u00edc\u00ed se stresem<\/td>\nGeneralizovan\u00fd strach, poruchy p\u0159izp\u016fsoben\u00ed a podpora p\u0159i odvyk\u00e1n\u00ed kou\u0159en\u00ed<\/td>\n<\/tr>\n
Klinick\u00e9 studie<\/strong><\/td>\nP\u0159ibli\u017en\u011b 15 klinick\u00fdch studi\u00ed v Rusku a na Ukrajin\u011b; v\u00fdsledky p\u0159\u00edzniv\u011bj\u0161\u00ed ne\u017e placebo a srovnateln\u00e9 se star\u0161\u00edmi anxiolytiky.<\/td>\nV\u00edce ne\u017e 20 klinick\u00fdch studi\u00ed v Rusku, n\u011bkter\u00e9 s \u00fa\u010dast\u00ed a\u017e 500 pacient\u016f; prok\u00e1z\u00e1ny p\u0159\u00ednosy oproti placebu<\/td>\n<\/tr>\n
Vliv na pam\u011b\u0165 a soust\u0159ed\u011bn\u00ed<\/strong><\/td>\nDob\u0159e zdokumentovan\u00e9 p\u0159\u00ednosy pro pracovn\u00ed pam\u011b\u0165, pozornost a ment\u00e1ln\u00ed v\u00fdkon, zejm\u00e9na ve stresov\u00fdch situac\u00edch.<\/td>\nKognitivn\u00ed p\u0159\u00ednosy se zdaj\u00ed b\u00fdt druho\u0159ad\u00e9 a nejsou hlavn\u00edm c\u00edlem v\u00fdzkumu<\/td>\n<\/tr>\n
Ne\u017e\u00e1douc\u00ed \u00fa\u010dinky<\/strong><\/td>\nM\u00edrn\u00e9 a vz\u00e1cn\u00e9: m\u00edrn\u00e9 podr\u00e1\u017ed\u011bn\u00ed nosu, p\u0159echodn\u00fd \u00fanavov\u00fd syndrom, ob\u010dasn\u00e1 bolest hlavy<\/td>\nM\u00edrn\u00e9 a vz\u00e1cn\u00e9: nevolnost, m\u00edrn\u00e9 za\u017e\u00edvac\u00ed pot\u00ed\u017ee a ob\u010dasn\u00e9 alergick\u00e9 reakce<\/td>\n<\/tr>\n
Interakce s jin\u00fdmi l\u00e1tkami<\/strong><\/td>\nNejsou zn\u00e1my \u017e\u00e1dn\u00e9 v\u00fdznamn\u00e9 interakce s jatern\u00edmi enzymy<\/td>\nMetabolizov\u00e1n pomoc\u00ed enzymu CYP3A4, proto m\u016f\u017ee interagovat s n\u011bkter\u00fdmi l\u00e9ky<\/td>\n<\/tr>\n
Nejv\u011bt\u0161\u00ed omezen\u00ed<\/strong><\/td>\nV\u011bt\u0161ina studi\u00ed byla provedena v\u00fdhradn\u011b v Rusku a na Ukrajin\u011b; omezen\u00e9 dlouhodob\u00e9 \u00fadaje<\/td>\nPodobne ograniczenia geograficzne oraz brak du\u017cych bada\u0144 klinicznych w USA, Wielkiej Brytanii i UE<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n<\/div>\n

Jak funguj\u00ed na \u00fazkost?<\/h2>\n

Oba p\u0159\u00edpravky sni\u017euj\u00ed p\u0159\u00edznaky \u00fazkosti, ale vyu\u017e\u00edvaj\u00ed odli\u0161n\u00e9 biologick\u00e9 mechanismy.<\/p>\n

Selank<\/h3>\n

V\u00fdzkumy nazna\u010duj\u00ed, \u017ee Selank:<\/p>\n

    \n
  • moduluje GABAergn\u00ed signalizaci,<\/li>\n
  • ovliv\u0148uje neurotrofick\u00e9 faktory, jako jsou BDNF a NGF,<\/li>\n
  • m\u016f\u017ee ovliv\u0148ovat serotoninov\u00fd a dopaminov\u00fd syst\u00e9m,<\/li>\n
  • vykazuje neuroregula\u010dn\u00ed a imunomodula\u010dn\u00ed vlastnosti.<\/li>\n<\/ul>\n

    Afobazol<\/h3>\n

    V\u00fdzkumy nazna\u010duj\u00ed, \u017ee Afobazol:<\/p>\n

      \n
    • aktivuje receptory sigma-1,<\/li>\n
    • podporuje adaptaci bun\u011bk na stres,<\/li>\n
    • m\u016f\u017ee ovliv\u0148ovat melatoninov\u00e9 receptory,<\/li>\n
    • zam\u011b\u0159uje se p\u0159edev\u0161\u00edm na regulaci chronick\u00e9ho stresu a \u00fazkosti.<\/li>\n<\/ul>\n

      \u017d\u00e1dn\u00fd z p\u0159\u00edpravk\u016f nebyl navr\u017een jako klasick\u00e9 sedativum a oba se zdaj\u00ed vykazovat n\u00edzk\u00e9 riziko sedace a z\u00e1vislosti.<\/p>\n

      Co funguje rychleji?<\/h2>\n

      Jedn\u00edm z nejv\u011bt\u0161\u00edch rozd\u00edl\u016f mezi t\u011bmito l\u00e1tkami je \u010das n\u00e1stupu \u00fa\u010dink\u016f.<\/p>\n

      Selank<\/strong> je zkoum\u00e1n p\u0159edev\u0161\u00edm v kontextu rychlej\u0161\u00ed redukce nap\u011bt\u00ed a stresu a podpory kognitivn\u00edch funkc\u00ed.<\/p>\n

      Afobazol<\/strong> obvykle vy\u017eaduje pravideln\u00e9 pou\u017e\u00edv\u00e1n\u00ed po n\u011bkolik t\u00fddn\u016f a \u010dast\u011bji se diskutuje v kontextu chronick\u00e9, p\u0159etrv\u00e1vaj\u00edc\u00ed \u00fazkosti.<\/p>\n

      Vliv na kognitivn\u00ed funkce<\/h2>\n

      V\u00fdzkum Selanku nazna\u010duje potenci\u00e1ln\u00ed p\u0159\u00ednosy t\u00fdkaj\u00edc\u00ed se:<\/p>\n

        \n
      • opera\u010dn\u00ed pam\u011b\u0165,<\/li>\n
      • koncentrace,<\/li>\n
      • odporno\u015bci na stres,<\/li>\n
      • funkc\u00ed pozn\u00e1vac\u00edch v situac\u00edch psychick\u00e9 z\u00e1t\u011b\u017ee.<\/li>\n<\/ul>\n

        Afobazol m\u016f\u017ee tak\u00e9 vykazovat ur\u010dit\u00e9 kognitivn\u00ed p\u0159\u00ednosy, av\u0161ak ty nepat\u0159\u00ed k jeho hlavn\u00edmu v\u00fdzkumn\u00e9mu zam\u011b\u0159en\u00ed.<\/p>\n

        Profil Bezpiecze\u0144stwa<\/h2>\n

        Dostupn\u00e9 studie nazna\u010duj\u00ed, \u017ee oba p\u0159\u00edpravky jsou obecn\u011b dob\u0159e sn\u00e1\u0161eny.<\/p>\n

        Selank:<\/strong><\/p>\n

          \n
        • ob\u010dasn\u00e9 podr\u00e1\u017ed\u011bn\u00ed nosu,<\/li>\n
        • bolest hlavy se z\u00e1chvatovit\u00fdm charakterem,<\/li>\n
        • p\u0159echodn\u00e1 \u00fanava.<\/li>\n<\/ul>\n

          Afobazol<\/strong><\/p>\n

            \n
          • m\u00edrn\u00e9 \u017ealude\u010dn\u00ed pot\u00ed\u017ee,<\/li>\n
          • nevolnosti,<\/li>\n
          • vz\u00e1cn\u00e9 alergick\u00e9 reakce.<\/li>\n<\/ul>\n

            V publikovan\u00fdch studi\u00edch nebylo pro \u017e\u00e1dn\u00fd z t\u011bchto p\u0159\u00edpravk\u016f zji\u0161t\u011bno v\u00fdznamn\u00e9 riziko z\u00e1vislosti ani abstinen\u010dn\u00ed p\u0159\u00edznaky.<\/p>\n

            Zastrze\u017cenie<\/h2>\n

            Obsah m\u00e1 v\u00fdhradn\u011b vzd\u011bl\u00e1vac\u00ed a informativn\u00ed charakter a nem\u011bl by b\u00fdt vykl\u00e1d\u00e1n jako l\u00e9ka\u0159sk\u00e1 rada, diagn\u00f3za ani l\u00e9\u010debn\u00e9 doporu\u010den\u00ed. Selank a Afobazol nebyly schv\u00e1leny americk\u00fdm \u00da\u0159adem pro kontrolu potravin a l\u00e9\u010div (FDA) ani Evropskou l\u00e9kovou agenturou (EMA) pro l\u00e9\u010dbu \u00fazkostn\u00fdch poruch nebo jin\u00fdch stav\u016f. V\u011bt\u0161ina dostupn\u00fdch \u00fadaj\u016f poch\u00e1z\u00ed ze studi\u00ed proveden\u00fdch v Rusku a v\u00fdchodn\u00ed Evrop\u011b. Dal\u0161\u00ed, dob\u0159e navr\u017een\u00e9 klinick\u00e9 studie jsou nezbytn\u00e9 k lep\u0161\u00edmu ur\u010den\u00ed jejich \u00fa\u010dinnosti, bezpe\u010dnosti a dlouhodob\u00fdch \u00fa\u010dink\u016f.<\/p>","protected":false},"excerpt":{"rendered":"

            Selank a Afobazol jsou dva rusk\u00e9 prepar\u00e1ty vyvinut\u00e9 s c\u00edlem sn\u00ed\u017eit \u00fazkost a zlep\u0161it odolnost v\u016f\u010di stresu. P\u0159esto\u017ee oba vykazuj\u00ed anxiolytick\u00e9 \u00fa\u010dinky, ani\u017e by vyvol\u00e1valy\u2026<\/p>","protected":false},"author":7908,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[192],"tags":[],"class_list":["post-51228","post","type-post","status-publish","format-standard","hentry","category-kategoria-selank","beh-no-thumb"],"_links":{"self":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/posts\/51228","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/users\/7908"}],"replies":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/comments?post=51228"}],"version-history":[{"count":0,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/posts\/51228\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/media?parent=51228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/categories?post=51228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/tags?post=51228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}